Examining B12 Deficiency Associated With C677T Mutation on MTHFR Gene in Terms of Commonness and Endothelial Function

NCT00730574 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2014-09-10

No results posted yet for this study

Summary

The purpose of this study is to determine the commonness of the C677T mutation in the MTHFR gene in subjects with B12 deficiency. Also, we'd like to investigate the effect of B12 deficiency combined with the C677T mutation on endothelial function.

Conditions

  • B12 Deficiency Combined With C677T Mutation on MTHFR Gene

Interventions

DIETARY_SUPPLEMENT

Vitamin B12 + Folic Acid

Trial group would get daily treatment of 1 mg Vitamin B12 combined with 5 mg Folic Acid

Sponsors & Collaborators

  • Moshe Flugelman

    lead OTHER

Principal Investigators

  • Moshe Y Flugelman · Carmel Medical Center, Haifa, Israel

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-03-31
Completion
2012-01-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00730574 on ClinicalTrials.gov